Tony Butler
Stock Analyst at Rodman & Renshaw
(1.07)
# 3,521
Out of 4,711 analysts
101
Total ratings
35%
Success rate
-12.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $11.40 | +119.30% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $4.48 | +145.54% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $4.23 | +325.53% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $3.18 | +371.70% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $2.91 | +174.91% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $1.10 | +1,354.55% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.60 | +1,553.17% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.68 | +495.24% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $40.72 | +84.18% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $41.85 | -16.37% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $1.75 | +3,338.40% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.53 | +749.67% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $14.68 | +240.60% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.87 | +702.14% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.69 | +3,511.15% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.69 | +787.57% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.21 | +4,661.90% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.73 | +1,270.05% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.76 | +515.94% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $2.83 | +5,765.72% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $12.49 | +380.38% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.25 | +3,115.43% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.68 | +787.71% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.45 | +1,904.45% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.66 | +2,459.86% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.01 | +199.40% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $3.80 | +163.16% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.38 | +986.96% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $12.18 | +803.12% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.97 | +8,147.42% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $11.40
Upside: +119.30%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $4.48
Upside: +145.54%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $4.23
Upside: +325.53%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $3.18
Upside: +371.70%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $2.91
Upside: +174.91%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $1.10
Upside: +1,354.55%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.60
Upside: +1,553.17%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.68
Upside: +495.24%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $40.72
Upside: +84.18%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $41.85
Upside: -16.37%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $1.75
Upside: +3,338.40%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.53
Upside: +749.67%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $14.68
Upside: +240.60%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.87
Upside: +702.14%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.69
Upside: +3,511.15%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.69
Upside: +787.57%
Jul 31, 2023
Initiates: Buy
Price Target: $10
Current: $0.21
Upside: +4,661.90%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $0.73
Upside: +1,270.05%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $2.76
Upside: +515.94%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $2.83
Upside: +5,765.72%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $12.49
Upside: +380.38%
Jun 5, 2023
Reiterates: Buy
Price Target: $8
Current: $0.25
Upside: +3,115.43%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.68
Upside: +787.71%
Jun 1, 2023
Assumes: Buy
Price Target: $9
Current: $0.45
Upside: +1,904.45%
May 25, 2023
Assumes: Buy
Price Target: $17
Current: $0.66
Upside: +2,459.86%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $5.01
Upside: +199.40%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $3.80
Upside: +163.16%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $1.38
Upside: +986.96%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $12.18
Upside: +803.12%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.97
Upside: +8,147.42%